Analysts Set Biogen Inc. (NASDAQ:BIIB) Target Price at $327.22
Shares of Biogen Inc. (NASDAQ:BIIB – Get Free Report) have been given an average rating of “Moderate Buy” by the twenty-five analysts that are presently covering the company, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold recommendation and twenty-one have issued a buy recommendation on the company. The average 1-year […]